Bone Biologics Corp. -CW26BBLGWPreferred / convertible
13F holders, Q1 2024 (March 31)3holders
1famous investor
$17.16avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Bone Biologics Corp. -CW26 (BBLGW) in their 13F filings. The largest holders were Citadel Advisors ($568K), Clear Street LLC ($2K) and Bank of America Corp. ($414). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bone Biologics Corp. -CW26
- CUSIP
- 098070154
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $570K |
| Exits | 1 | $45K |
Ownership 3 holders
| Citadel Advisors | — | New | 33,037 | $568K |
| Clear Street LLC | — | New | 100 | $2K |
| Bank of America Corp. | — | New | 100 | $414 |
"% of holder's portfolio" is BBLGW's weight in each manager's 13F, not the share of Bone Biologics Corp. -CW26 the manager owns.